- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05361980
Bezpieczeństwo i skuteczność implantów ortopedycznych dla dzieci (Global POISE)
Prospektywny obserwacyjny program obserwacji klinicznej bezpieczeństwa i skuteczności implantów
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.
Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.
Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.
Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.
Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.
Required Data Collection:
Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.
The following data will be collected and entered into the registry:
- Operative data, specific to the technique related to the relevant OrthoPediatrics system/device
- Assessments of any device-related adverse events
- Assessment for other adverse events
- When possible, the UDI number for the device(s) implanted, or information on the device implanted
Follow-up Procedures
Data collected during routine standard of care follow-up visits will be collected as part of this study. The following data will be collected:
- Radiographs obtained during study clinical evaluations to determine bony union, as well as healing or complications
- Device-related adverse events
- Unanticipated device-related serious adverse device effects
- Information on implant removals not related to an adverse event; degree of bony union just prior to implant removal Unscheduled Visits [if or when needed]
The condition-specific registries are designed to capture every visit that occurs, whether scheduled or unscheduled. An unscheduled visit may occur when an adverse event occurs, or when a patient returns outside of the planned interval window. If an unscheduled visit occurs, the following assessments are to be done:
- Assessment of any adverse events related to the device
- Survivorship of the device
Typ studiów
Zapisy (Szacowany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Harpreet Chhina, PhD
- Numer telefonu: 6008 604-875-2000
- E-mail: hchhina@cw.bc.ca
Kopia zapasowa kontaktu do badania
- Nazwa: Bryn Zomar, PhD
- Numer telefonu: 604-875-2359
- E-mail: bryn.zomar@cw.bc.ca
Lokalizacje studiów
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V6H 3N1
- Rekrutacyjny
- BC Children's Hospital
-
Kontakt:
- Emily Schaeffer, PhD
- Numer telefonu: 604-875-2359
- E-mail: emily.schaeffer@cw.bc.ca
-
Główny śledczy:
- Anthony Cooper, FRCSC
-
Główny śledczy:
- Kishore Mulpuri, FRCSC
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Anyone who meets the eligibility criteria and is within the age limits listed in the above sections can participate in this study.
Opis
Inclusion Criteria:
- Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly
- Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
- Informed consent/assent is required
Exclusion Criteria:
- Patients with a demonstrated sensitivity to metals
- Patients with an inability to follow a post-operative regimen
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: COHORT
- Perspektywy czasowe: PROSPECTIVE
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Longitudinal Observational Group
Pediatric patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. |
Patient receives a pediatric orthopaedic implant as a part of standard clinical care. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Device related adverse events
Ramy czasowe: 2 years post implant insertion
|
Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed. |
2 years post implant insertion
|
|
Implant survival
Ramy czasowe: 2 years post implant insertion
|
Determine the implant survival rate at post-operative end-point: (lack of revision) |
2 years post implant insertion
|
|
Implant efficacy
Ramy czasowe: 2 years post implant insertion
|
Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction. |
2 years post implant insertion
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Numeric pain rating scale (NPRS)
Ramy czasowe: 2 years post implant insertion
|
The numeric pain rating scale (NPRS) is a subjective, 11-point numerical scale in which respondents self-report their pain on a scale of 0 (no pain at all) to 10 (worst pain imaginable). |
2 years post implant insertion
|
|
LIMB-Q Kids
Ramy czasowe: 2 years post implant insertion
|
LIMB-Q Kids is a new patient reported outcome measure (PROM) for children with lower limb deformities. |
2 years post implant insertion
|
|
PROMIS
Ramy czasowe: 2 years post implant insertion
|
The Patient Reported Outcomes Measurement Information System (PROMIS) measures are self-reported and parent-reported. It includes over 300 measures of global, physical, mental, and social health for adults and children in the general population and those living with a chronic condition. Specifically, the PROMIS Global Health will be administered to all patients while the PROMIS Physical Function - Mobility short form will be administered to those with an implant used in a lower extremity and the PROMIS Physical Function - Upper Extremity short form will be administered to those with an implant used in an upper extremity. |
2 years post implant insertion
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Dyrektor Studium: Bryn Zomar, PhD, University of British Columbia
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Rany i urazy
- Nowotwory
- Choroby stawów
- Choroby układu odpornościowego
- Nowotwory według typu histologicznego
- Choroby hematologiczne
- Choroby limfatyczne
- Zaburzenia limfoproliferacyjne
- Zaburzenia immunoproliferacyjne
- Białaczka, układ limfatyczny
- Białaczka
- Urazy biodra
- Zwichnięcia stawów
- Wrodzone, dziedziczne i noworodkowe choroby i nieprawidłowości
- Choroby hemowe i limfatyczne
- Wady wrodzone
- Złamania, kości
- Prekursorowa komórkowa białaczka limfoblastyczna-chłoniak
- Choroby układu mięśniowo-szkieletowego
- Zwichnięcie stawu biodrowego
Inne numery identyfikacyjne badania
- H21-03076
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
produkt wyprodukowany i wyeksportowany z USA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .